Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.76 USD | -3.41% | -2.65% | 0.00% |
May. 14 | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.05B | - | - | - | - | - | |
62.59B | - | |||||
41.18B | ||||||
40.29B | ||||||
27.9B | ||||||
26.21B |
- Stock Market
- Equities
- CGON Stock
- Charts CG Oncology, Inc.
- Sector Chart